Atlas Trials

Efficacy and Safety Study of 4-Day ATG Regimen for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT

Clinical trial NCT05214066 · UNKNOWN

Trial details

NCT number
NCT05214066
Sponsor
Chinese PLA General Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
aGVHDcGVHD
Start date
2019-02-01
Primary completion
2022-08-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.